tetano
Editor, Senior Moderator
Am J Transplant. 2020 Apr 23. doi: 10.1111/ajt.15935. [Epub ahead of print]
Covid-19 pneumonia in a kidney transplant recipient successfully treated with Tocilizumab and Hydroxychloroquine.
Fontana F[SUP]1[/SUP], Alfano G[SUP]1,[/SUP][SUP]2[/SUP], Mori G[SUP]1[/SUP], Amurri A[SUP]2[/SUP], Lorenzo T[SUP]2[/SUP], Ballestri M[SUP]1[/SUP], Leonelli M[SUP]1[/SUP], Facchini F[SUP]1[/SUP], Damiano F[SUP]1[/SUP], Magistroni R[SUP]1,[/SUP][SUP]2[/SUP], Cappelli G[SUP]1,[/SUP][SUP]2[/SUP].
Author information
Abstract
Coronavirus disease 2019 (Covid-19) pneumonia has been poorly reported in solid-organ transplanted patients; prognosis is uncertain and best management unclear. We describe the case of a 61-year-old kidney transplant recipient with several co-morbidities who was hospitalized and later received a diagnosis of Covid-19 pneumonia; the infection was successfully managed with the use of hydroxychloroquine and a single administration of Tocilizumab, after immunosuppression reduction; the patient did not require mechanical ventilation. During the rapid spread of SARS-CoV-2 pandemic, transplant clinicians should be readily informed about new cases of Covid-19 pneumonia in solid-organ transplant recipients, with focus on therapeutic strategies employed and their outcome.
This article is protected by copyright. All rights reserved.
PMID:32324331DOI:10.1111/ajt.15935
Covid-19 pneumonia in a kidney transplant recipient successfully treated with Tocilizumab and Hydroxychloroquine.
Fontana F[SUP]1[/SUP], Alfano G[SUP]1,[/SUP][SUP]2[/SUP], Mori G[SUP]1[/SUP], Amurri A[SUP]2[/SUP], Lorenzo T[SUP]2[/SUP], Ballestri M[SUP]1[/SUP], Leonelli M[SUP]1[/SUP], Facchini F[SUP]1[/SUP], Damiano F[SUP]1[/SUP], Magistroni R[SUP]1,[/SUP][SUP]2[/SUP], Cappelli G[SUP]1,[/SUP][SUP]2[/SUP].
Author information
Abstract
Coronavirus disease 2019 (Covid-19) pneumonia has been poorly reported in solid-organ transplanted patients; prognosis is uncertain and best management unclear. We describe the case of a 61-year-old kidney transplant recipient with several co-morbidities who was hospitalized and later received a diagnosis of Covid-19 pneumonia; the infection was successfully managed with the use of hydroxychloroquine and a single administration of Tocilizumab, after immunosuppression reduction; the patient did not require mechanical ventilation. During the rapid spread of SARS-CoV-2 pandemic, transplant clinicians should be readily informed about new cases of Covid-19 pneumonia in solid-organ transplant recipients, with focus on therapeutic strategies employed and their outcome.
This article is protected by copyright. All rights reserved.
PMID:32324331DOI:10.1111/ajt.15935